Self-Regulatory Organizations; NYSE Arca, Inc.; Order Approving a Proposed Rule Change, as Modified by Amendment No. 1 Thereto, Regarding the Listing and Trading of Shares of the PGIM Ultra Short Bond ETF, 65189-65190 [2018-27407]
Download as PDF
Federal Register / Vol. 83, No. 243 / Wednesday, December 19, 2018 / Notices
(‘‘Commission’’), pursuant to Section
19(b)(1) of the Securities Exchange Act
of 1934 (‘‘Act’’) 1 and Rule 19b–4
thereunder,2 a proposed rule change to
permit the listing and trading of P.M.settled series on certain broad-based
index options on a pilot basis. The
proposed rule change was published for
comment in the Federal Register on
October 30, 2018.3 The Commission has
received no comment letters on the
proposed rule change.
Section 19(b)(2) of the Act 4 provides
that, within 45 days of the publication
of notice of the filing of a proposed rule
change, or within such longer period up
to 90 days as the Commission may
designate if it finds such longer period
to be appropriate and publishes its
reasons for so finding or as to which the
self-regulatory organization consents,
the Commission shall either approve the
proposed rule change, disapprove the
proposed rule change, or institute
proceedings to determine whether the
proposed rule change should be
disapproved. The 45th day after
publication of the notice for this
proposed rule change is December 14,
2018. The Commission is extending this
45-day time period.
The Commission finds that it is
appropriate to designate a longer period
within which to take action on the
proposed rule change so that it has
sufficient time to consider the proposed
rule change. Accordingly, the
Commission, pursuant to Section
19(b)(2) of the Act,5 designates January
28, 2019 as the date by which the
Commission shall either approve or
disapprove or institute proceedings to
determine whether to disapprove the
proposed rule change (File Number SR–
CboeEDGX–2018–037).
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.6
Eduardo A. Aleman,
Deputy Secretary.
[FR Doc. 2018–27404 Filed 12–18–18; 8:45 am]
amozie on DSK3GDR082PROD with NOTICES1
BILLING CODE 8011–01–P
1 15
U.S.C. 78s(b)(1).
CFR 240.19b–4.
3 See Securities Exchange Act Release No. 84481
(Oct. 24, 2018), 83 FR 54624.
4 15 U.S.C. 78s(b)(2).
5 Id.
6 17 CFR 200.30–3(a)(31).
2 17
VerDate Sep<11>2014
17:59 Dec 18, 2018
Jkt 247001
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–84818; File No. SR–
NYSEArca–2018–75]
Self-Regulatory Organizations; NYSE
Arca, Inc.; Order Approving a
Proposed Rule Change, as Modified by
Amendment No. 1 Thereto, Regarding
the Listing and Trading of Shares of
the PGIM Ultra Short Bond ETF
December 13, 2018.
I. Introduction
On October 12, 2018, NYSE Arca, Inc.
(‘‘Exchange’’ or ‘‘NYSE Arca’’) filed
with the Securities and Exchange
Commission (‘‘Commission’’), pursuant
to Section 19(b)(1) of the Securities
Exchange Act of 1934 (‘‘Act’’) 1 and Rule
19b–4 thereunder,2 a proposed rule
change to modify the rule governing the
listing and trading of shares (‘‘Shares’’)
of the PGIM Ultra Short Bond ETF
(‘‘Fund’’). The Commission previously
approved the listing and trading of the
Shares subject to a representation that
the Fund’s investments in OTC
derivatives would not exceed 20% of
the Fund’s net assets.3 The Exchange
now seeks to permit the Fund to invest
up to 50% of its net assets in OTC
derivatives under certain circumstances.
The proposed rule change was
published for comment in the Federal
Register on October 31, 2018.4 On
November 7, 2018, the Exchange filed
Amendment No. 1 to the proposed rule
change.5 The Commission has not
received any comments on the proposed
rule change. This order approves the
proposed rule change, as modified by
Amendment No. 1.
II. Description of the Proposed Rule
Change, as Modified by Amendment
No. 1
The Shares are Managed Fund Shares
that do not satisfy all of the criteria for
generic listing set forth in Commentary
1 15
U.S.C. 78s(b)(1).
CFR 240.19b–4.
3 See Securities Exchange Act Release No. 83319
(May 24, 2018), 83 FR 25097 (May 31, 2018) (SR–
NYSEArca–2018–15) (‘‘Prior Order’’).
4 See Securities Exchange Act Release No. 84486
(Oct. 25, 2018), 83 FR 54794 (‘‘Notice’’).
5 In Amendment No. 1, the Exchange: (1)
Corrected its description of the current listing rule
applicable to the Shares; (2) clarified the scope of
the Fund’s permitted investments in over-thecounter (‘‘OTC’’) derivatives; (3) supplemented its
arguments in support of the proposed rule change;
and (4) made technical changes. Amendment No. 1
is available at: https://www.sec.gov/comments/srnyseArca-2018-75/srnysearca201875-4628265-176
398.pdf. Amendment No. 1 is not subject to notice
and comment because it does not materially alter
the substance of the proposed rule change or raise
unique or novel regulatory issues.
2 17
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
65189
.01 to NYSE Arca Rule 8.600–E. Thus,
the Exchange currently lists and trades
the Shares pursuant to a rule (‘‘Listing
Rule’’) approved by Commission.6 The
Listing Rule requires that the Fund’s
portfolio meet all requirements of
Commentary .01 to NYSE Arca Rule
8.600–E except for those set forth in
Commentary .01(a)(1), Commentary
.01(b)(4) and Commentary .01(b)(5).7
Accordingly, the Listing Rule limits the
Fund’s investments in OTC derivatives
to 20% of the Fund’s assets and, for
purposes of calculating this limit, the
portfolio’s investment in OTC
derivatives is calculated using the
aggregate gross notional value of the
OTC derivatives.8
The Exchange proposes to allow: (1)
Up to 50% of the Fund’s assets to be
invested in OTC derivatives that are
used to reduce currency, interest rate,
credit, or duration risk arising from the
Fund’s investments (‘‘Hedging
Derivatives’’); and (2) up to 20% of the
Fund’s assets to be invested in OTC
derivatives other than Hedging
Derivatives. For purposes of calculating
the proposed alternative limits, the
portfolio’s investments in OTC
derivatives would be calculated using
the aggregate gross notional value of the
OTC derivatives.
According to the Exchange, the
Fund’s adviser and sub-adviser believe
that it is important to provide the Fund
with additional flexibility to manage
risk associated with its investments and,
depending on market conditions, it may
be necessary for the Fund to utilize
additional OTC derivatives for this
purpose.9 Generally, according to the
Exchange, OTC derivatives may be
customized to a greater degree than
exchange-listed derivatives, which may
allow the Fund to better hedge its assets
and may mitigate trading its costs.10
The Exchange also states that the
Commission has previously approved
an exception from the requirements of
Commentary .01(e) relating to
investments in OTC derivatives similar
to those proposed with respect to the
Fund.11
III. Discussion
After careful review, the Commission
finds that the Exchange’s proposed rule
change, as modified by Amendment No.
1, to amend the Listing Rule applicable
to the Shares consistent with the Act
and the rules and regulations
6 See
Prior Order, supra note 3.
id.
8 See Commentary .01(e) to NYSE Arca Rule
8.600–E.
9 See Notice, supra note 3, 83 FR at 59794.
10 See id.
11 See id., 83 FR at 54794, n.10.
7 See
E:\FR\FM\19DEN1.SGM
19DEN1
65190
Federal Register / Vol. 83, No. 243 / Wednesday, December 19, 2018 / Notices
thereunder applicable to a national
securities exchange.12 The Exchange
proposes to modify only the Listing
Rule’s limit on OTC derivatives, and the
proposed alternative limits are
substantially similar to OTC derivatives
limits for another issue of Managed
Fund Shares that also invests
principally in fixed-income securities.13
The Commission approved a listing rule
allowing that fund to similarly invest up
to: (1) 50% of its assets in OTC
derivatives to reduce currency, interest
rate, or credit risk arising from the
fund’s investments; and (2) 20% of its
assets in OTC derivatives other than
OTC derivatives used to hedge the
fund’s portfolio against currency,
interest rate, or credit risk.14
For the foregoing reason, the
Commission finds that the proposed
rule change, as modified by Amendment
No. 1, is consistent with of the Act and
the rules and regulations thereunder
applicable to a national securities
exchange.
IV. Conclusion
It is therefore ordered, pursuant to
Section 19(b)(2) of the Exchange Act,15
that the proposed rule change (SR–
NYSEArca–2018–75), as modified by
Amendment No. 1 be, and it hereby is,
approved.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.16
Eduardo A. Aleman,
Deputy Secretary.
[FR Doc. 2018–27407 Filed 12–18–18; 8:45 am]
amozie on DSK3GDR082PROD with NOTICES1
BILLING CODE 8011–01–P
12 In approving this proposed rule change, the
Commission has considered the proposed rule’s
impact on efficiency, competition, and capital
formation. See 15 U.S.C. 78c(f).
13 See Securities Exchange Act Release No. 80657
(May 11, 2017), 82 FR 22702 (May 17, 2017) (SR–
NYSEArca–2017–09). The Commission also notes
that the proposed alternative limits are consistent
with derivatives requirements in listing rules for
another issue of Managed Fund Shares. See
Securities Exchange Act Release No. 84047
(September 6, 2018), 83 FR 46200 (September 12,
2018) (SR–NASDAQ–2017–128).
14 See Securities Exchange Act Release No. 80657,
supra note 13. The addition of duration risk to the
uses of Hedging Derivative in the current proposal
does not alter the Commission’s analysis.
15 15 U.S.C. 78s(b)(2).
16 17 CFR 200.30–3(a)(12).
VerDate Sep<11>2014
17:59 Dec 18, 2018
Jkt 247001
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–84819; File No. SR–
NYSEArca–2018–90]
Self-Regulatory Organizations; NYSE
Arca, Inc.; Notice of Filing and
Immediate Effectiveness of Proposed
Rule Change Amending the NYSE Arca
Equities Fees and Charges
December 13, 2018.
Pursuant to Section 19(b)(1) 1 of the
Securities Exchange Act of 1934 (the
‘‘Act’’) 2 and Rule 19b–4 thereunder,3
notice is hereby given that, on December
3, 2018, NYSE Arca, Inc. (the
‘‘Exchange’’ or ‘‘NYSE Arca’’) filed with
the Securities and Exchange
Commission (the ‘‘Commission’’) the
proposed rule change as described in
Items I, II, and III below, which Items
have been prepared by the selfregulatory organization. The
Commission is publishing this notice to
solicit comments on the proposed rule
change from interested persons.
I. Self-Regulatory Organization’s
Statement of the Terms of Substance of
the Proposed Rule Change
The Exchange proposes to amend the
NYSE Arca Equities Fees and Charges
(‘‘Fee Schedule’’). The proposed rule
change is available on the Exchange’s
website at www.nyse.com, at the
principal office of the Exchange, and at
the Commission’s Public Reference
Room.
II. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
In its filing with the Commission, the
self-regulatory organization included
statements concerning the purpose of,
and basis for, the proposed rule change
and discussed any comments it received
on the proposed rule change. The text
of those statements may be examined at
the places specified in Item IV below.
The Exchange has prepared summaries,
set forth in sections A, B, and C below,
of the most significant parts of such
statements.
A. Self-Regulatory Organization’s
Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule
Change
1. Purpose
The Exchange proposes to amend the
Fee Schedule by increasing the credit
1 15
U.S.C. 78s(b)(1).
U.S.C. 78a.
3 17 CFR 240.19b–4.
2 15
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
applicable to the Retail Order Step-Up
Tier 2, as described below.
The Exchange currently has a Retail
Order Step-Up Tier 2 credit of $0.0035
per share for Retail Orders 4 that provide
displayed liquidity during the month in
Tape A, Tape B and Tape C Securities
that applies to ETP Holders, including
Market Makers, that provide liquidity an
average daily share volume per month
of 1.10% or more of the U.S. CADV, and
execute an ADV of Retail Orders with a
time-in-force designation of Day that
add or remove liquidity during the
month that is an increase of 0.35% or
more of the U.S. CADV above their
April 2018 ADV taken as a percentage
of U.S. CADV. Retail Orders with a
time-in-force designation of Day that
remove liquidity from the Book are not
charged a fee.5 The Exchange proposes
to increase the current credit for Retail
Orders that provide displayed liquidity
during the month in Tape A, Tape B and
Tape C Securities to $0.0038 per share.
The Exchange is not proposing any
other change to the Retail Order StepUp Tier 2.
For all other fees and credits, tiered or
basic rates apply based on a firm’s
qualifying levels.
2. Statutory Basis
The Exchange believes that the
proposed rule change is consistent with
Section 6(b) of the Act,6 in general, and
furthers the objectives of Sections
6(b)(4) and (5) of the Act,7 in particular,
because it provides for the equitable
allocation of reasonable dues, fees, and
other charges among its members,
issuers and other persons using its
facilities and does not unfairly
discriminate between customers,
issuers, brokers or dealers.
4 A Retail Order is an agency order that originates
from a natural person and is submitted to the
Exchange by an ETP Holder, provided that no
change is made to the terms of the order to price
or side of market and the order does not originate
from a trading algorithm or any other computerized
methodology. See Securities Exchange Act Release
No. 67540 (July 30, 2012), 77 FR 46539 (August 3,
2012) (SR–NYSEArca–2012–77).
5 See Securities Exchange Act Release No. 83828
(August 10, 2018), 83 FR 40816 (August 16, 2018)
(SR–NYSEArca–2018–58). An ETP Holder that
qualifies for the Retail Order Step-Up Tier 2 also
receives a credit of $0.0035 per share for orders (not
just Retail Orders) that provide displayed liquidity
to the order book in Tape C Securities, and an
incremental credit of $0.0002 per share for orders
that provide non-displayed liquidity to the order
book in Tape C Securities. The incremental credit
is in addition to the ETP Holder’s or Market Maker’s
Tiered or Basic Rate credit(s). Pursuant to the Retail
Order Step-Up Tier 2, ETP Holders and Market
Makers pay a fee of $0.0027 per share for orders that
take liquidity from the order book in Tape C
Securities.
6 15 U.S.C. 78f(b).
7 15 U.S.C. 78f(b)(4) and (5).
E:\FR\FM\19DEN1.SGM
19DEN1
Agencies
[Federal Register Volume 83, Number 243 (Wednesday, December 19, 2018)]
[Notices]
[Pages 65189-65190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27407]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[Release No. 34-84818; File No. SR-NYSEArca-2018-75]
Self-Regulatory Organizations; NYSE Arca, Inc.; Order Approving a
Proposed Rule Change, as Modified by Amendment No. 1 Thereto, Regarding
the Listing and Trading of Shares of the PGIM Ultra Short Bond ETF
December 13, 2018.
I. Introduction
On October 12, 2018, NYSE Arca, Inc. (``Exchange'' or ``NYSE
Arca'') filed with the Securities and Exchange Commission
(``Commission''), pursuant to Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder,\2\ a
proposed rule change to modify the rule governing the listing and
trading of shares (``Shares'') of the PGIM Ultra Short Bond ETF
(``Fund''). The Commission previously approved the listing and trading
of the Shares subject to a representation that the Fund's investments
in OTC derivatives would not exceed 20% of the Fund's net assets.\3\
The Exchange now seeks to permit the Fund to invest up to 50% of its
net assets in OTC derivatives under certain circumstances.
---------------------------------------------------------------------------
\1\ 15 U.S.C. 78s(b)(1).
\2\ 17 CFR 240.19b-4.
\3\ See Securities Exchange Act Release No. 83319 (May 24,
2018), 83 FR 25097 (May 31, 2018) (SR-NYSEArca-2018-15) (``Prior
Order'').
---------------------------------------------------------------------------
The proposed rule change was published for comment in the Federal
Register on October 31, 2018.\4\ On November 7, 2018, the Exchange
filed Amendment No. 1 to the proposed rule change.\5\ The Commission
has not received any comments on the proposed rule change. This order
approves the proposed rule change, as modified by Amendment No. 1.
---------------------------------------------------------------------------
\4\ See Securities Exchange Act Release No. 84486 (Oct. 25,
2018), 83 FR 54794 (``Notice'').
\5\ In Amendment No. 1, the Exchange: (1) Corrected its
description of the current listing rule applicable to the Shares;
(2) clarified the scope of the Fund's permitted investments in over-
the-counter (``OTC'') derivatives; (3) supplemented its arguments in
support of the proposed rule change; and (4) made technical changes.
Amendment No. 1 is available at: https://www.sec.gov/comments/sr-nyseArca-2018-75/srnysearca201875-4628265-176398.pdf. Amendment No.
1 is not subject to notice and comment because it does not
materially alter the substance of the proposed rule change or raise
unique or novel regulatory issues.
---------------------------------------------------------------------------
II. Description of the Proposed Rule Change, as Modified by Amendment
No. 1
The Shares are Managed Fund Shares that do not satisfy all of the
criteria for generic listing set forth in Commentary .01 to NYSE Arca
Rule 8.600-E. Thus, the Exchange currently lists and trades the Shares
pursuant to a rule (``Listing Rule'') approved by Commission.\6\ The
Listing Rule requires that the Fund's portfolio meet all requirements
of Commentary .01 to NYSE Arca Rule 8.600-E except for those set forth
in Commentary .01(a)(1), Commentary .01(b)(4) and Commentary
.01(b)(5).\7\ Accordingly, the Listing Rule limits the Fund's
investments in OTC derivatives to 20% of the Fund's assets and, for
purposes of calculating this limit, the portfolio's investment in OTC
derivatives is calculated using the aggregate gross notional value of
the OTC derivatives.\8\
---------------------------------------------------------------------------
\6\ See Prior Order, supra note 3.
\7\ See id.
\8\ See Commentary .01(e) to NYSE Arca Rule 8.600-E.
---------------------------------------------------------------------------
The Exchange proposes to allow: (1) Up to 50% of the Fund's assets
to be invested in OTC derivatives that are used to reduce currency,
interest rate, credit, or duration risk arising from the Fund's
investments (``Hedging Derivatives''); and (2) up to 20% of the Fund's
assets to be invested in OTC derivatives other than Hedging
Derivatives. For purposes of calculating the proposed alternative
limits, the portfolio's investments in OTC derivatives would be
calculated using the aggregate gross notional value of the OTC
derivatives.
According to the Exchange, the Fund's adviser and sub-adviser
believe that it is important to provide the Fund with additional
flexibility to manage risk associated with its investments and,
depending on market conditions, it may be necessary for the Fund to
utilize additional OTC derivatives for this purpose.\9\ Generally,
according to the Exchange, OTC derivatives may be customized to a
greater degree than exchange-listed derivatives, which may allow the
Fund to better hedge its assets and may mitigate trading its costs.\10\
---------------------------------------------------------------------------
\9\ See Notice, supra note 3, 83 FR at 59794.
\10\ See id.
---------------------------------------------------------------------------
The Exchange also states that the Commission has previously
approved an exception from the requirements of Commentary .01(e)
relating to investments in OTC derivatives similar to those proposed
with respect to the Fund.\11\
---------------------------------------------------------------------------
\11\ See id., 83 FR at 54794, n.10.
---------------------------------------------------------------------------
III. Discussion
After careful review, the Commission finds that the Exchange's
proposed rule change, as modified by Amendment No. 1, to amend the
Listing Rule applicable to the Shares consistent with the Act and the
rules and regulations
[[Page 65190]]
thereunder applicable to a national securities exchange.\12\ The
Exchange proposes to modify only the Listing Rule's limit on OTC
derivatives, and the proposed alternative limits are substantially
similar to OTC derivatives limits for another issue of Managed Fund
Shares that also invests principally in fixed-income securities.\13\
The Commission approved a listing rule allowing that fund to similarly
invest up to: (1) 50% of its assets in OTC derivatives to reduce
currency, interest rate, or credit risk arising from the fund's
investments; and (2) 20% of its assets in OTC derivatives other than
OTC derivatives used to hedge the fund's portfolio against currency,
interest rate, or credit risk.\14\
---------------------------------------------------------------------------
\12\ In approving this proposed rule change, the Commission has
considered the proposed rule's impact on efficiency, competition,
and capital formation. See 15 U.S.C. 78c(f).
\13\ See Securities Exchange Act Release No. 80657 (May 11,
2017), 82 FR 22702 (May 17, 2017) (SR-NYSEArca-2017-09). The
Commission also notes that the proposed alternative limits are
consistent with derivatives requirements in listing rules for
another issue of Managed Fund Shares. See Securities Exchange Act
Release No. 84047 (September 6, 2018), 83 FR 46200 (September 12,
2018) (SR-NASDAQ-2017-128).
\14\ See Securities Exchange Act Release No. 80657, supra note
13. The addition of duration risk to the uses of Hedging Derivative
in the current proposal does not alter the Commission's analysis.
---------------------------------------------------------------------------
For the foregoing reason, the Commission finds that the proposed
rule change, as modified by Amendment No. 1, is consistent with of the
Act and the rules and regulations thereunder applicable to a national
securities exchange.
IV. Conclusion
It is therefore ordered, pursuant to Section 19(b)(2) of the
Exchange Act,\15\ that the proposed rule change (SR-NYSEArca-2018-75),
as modified by Amendment No. 1 be, and it hereby is, approved.
---------------------------------------------------------------------------
\15\ 15 U.S.C. 78s(b)(2).
For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\16\
---------------------------------------------------------------------------
\16\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------
Eduardo A. Aleman,
Deputy Secretary.
[FR Doc. 2018-27407 Filed 12-18-18; 8:45 am]
BILLING CODE 8011-01-P